Gerard Brophy - 20 Feb 2023 Form 4 Insider Report for Avantor, Inc. (AVTR)

Role
EVP, Biopharma Production
Signature
/s/ Scott Baker, as Attorney-in-Fact
Issuer symbol
AVTR
Transactions as of
20 Feb 2023
Transactions value $
-$75,387
Form type
4
Filing time
22 Feb 2023, 15:58:52 UTC
Previous filing
02 Feb 2023
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTR Common Stock Tax liability -$75,386 -3,072 -3% $24.54 99,313 20 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.